Union Budget 2025: Pharma industry applauds key provisions on drug accessibility, R&D boost Read more
Exemptions, concessional duty on essential medicines to improve drug access: Sudarshan Jain, IPA Read more
Budget expectations: Leaders opine for incentives in the nutra and API manufacturing sectors Read more
Bolstering India’s healthcare innovation in cancer, rare diseases: How Budget 2025 can make a difference? Read more
